Flexible stretch stent-graft
US-2017035548-A1 · Feb 9, 2017 · US
US12173125B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12173125-B2 |
| Application number | US-202016744497-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 16, 2020 |
| Priority date | Jan 16, 2020 |
| Publication date | Dec 24, 2024 |
| Grant date | Dec 24, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of making polytetrafluoroethylene (PTFE)/polymer composites are disclosed herein. The products can be used in the field of bio- and medical applications, such as for use in artificial blood vessels, vascular grafts, cardiovascular and soft tissue patches, facial implants, surgical sutures, and endovascular prosthesis, and for any products known in the aerospace, electronics, fabrics, filtration, industrial and sealant arts.
Opening claim text (preview).
What is claimed is: 1. A process for preparing a polytetrafluoroethylene (PTFE)/polymer composite product, the process comprising: dissolving a polymer with a solvent to form a polymer solution; immersing a PTFE material into the polymer solution to uniformly coat the PTFE material with the polymer solution; evaporating the solvent from the PTFE/polymer solution by heating the PTFE/polymer solution to a temperature of from 60° C. to about 200° C. for a period of from about 0.5 minutes to about 120 minutes to form a PTFE/polymer blend; adding a lubricant to the PTFE/polymer blend; and extruding the PTFE/polymer blend. 2. The process as set forth in claim 1 , wherein the solvent is a biocompatible lower alkyl (C 1 -C 10 ) alcohol selected from the group consisting of methanol, ethanol, isopropanol, and combinations thereof. 3. The process as set forth in claim 1 , wherein the solvent is selected from the group consisting of acetic acid, ethyl acetate, acetonitrile, chloroform, benzene, methylbenzene, dimethylbenzene, acetone, 2-butanone, cyclopentanone, pentane, n-hexane, cyclohexane, heptane, dichloromethane, dichloroethane, trichloroethane, tetrachloromethane, tetrachloroethane, trimethylpentane, 1,4-dioxane, ether, dimethyl sulfoxide (DMSO), dimethylformamide (DMF), tetrahydrofuran (THF), and combinations thereof. 4. The process as set forth in claim 1 , wherein the polymer is selected from the group consisting of polylactic acid (PLA), polycaprolactone (PCL), thermoplastic polyurethane (TPU), polyvinyl alcohol (PVA), poly(ethylene oxide) (PEO), polycarbonate (PC), polystyrene (PS), polyamide (PA), polyacrylonitrile (PAN), and combinations thereof. 5. The process as set forth in claim 1 , wherein the lubricant is the same as the solvent. 6. The process as set forth in claim 1 , wherein the solvent is further mixed with water before dissolving the polymer and the solvent/water mixture has a weight ratio of 70:30. 7. The process as set forth in claim 1 , wherein immersing the PTFE material comprises roll blending the PTFE material and the polymer solution for a period of from about 30 minutes to about 120 minutes. 8. The process as set forth in claim 7 further comprising soaking the blend for a period of from about 30 minutes to about 48 hours after rolling. 9. The process as set forth in claim 1 further comprising preforming the PTFE/polymer blend and extruding the preformed blend to form an extruded composite product. 10. The process as set forth in claim 9 comprising preforming the PTFE/polymer blend at a pressure of from about 1 MPa to about 30 MPa. 11. The process as set forth in claim 1 further comprising expanding the extruded product. 12. The process as set forth in claim 11 , wherein the expanding is conducted at a temperature of from about 25° C. to about 340° C. 13. The process as set forth in claim 11 , wherein the extruded product is expanded at a rate of from about 1 mm/min to about 1000 mm/min. 14. The process as set forth in claim 11 , wherein the extruded product is expanded at an expansion ratio of from about 100% to about 800%. 15. The process as set forth in claim 1 further comprising dissolving a target material in the polymer solution.
Extruding materials comprising incompatible ingredients · CPC title
using organic solvents · CPC title
by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out · CPC title
Medical applications, e.g. biocompatible scaffolds · CPC title
Elimination of a polymeric phase · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.